後天聽力障礙可以是由於患病、使用藥物、暴露於高聲浪及頭部受創等因素造成。美國Florida Hospital for Children開始了一項FDA規管的臨床測試,研究使用臍血幹細胞去幫助啟動身體的自我修復機制能否成為一個非侵入性的治療選擇。
臨床測試的研究對象是10個介乎6星期至6歲的小朋友,他們均在少於18個月內被診斷患上後天聽力障礙並曾在出生時儲存臍帶血。研究對象會接受自身臍血幹細胞移植,測試的主要目標是探討使用臍血幹細胞的安全及評估治療能否改善內耳功能及語言能力等。
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |